SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Chemistry

Medicine

Immunology

Show all topics

DOI

10.1101/2020.09.30.317818

License

CC-BY-NC-ND

Other Formats

PDF